Century Complete Announces New Homes Now Selling in Prescott Valley, Arizona
PRESCOTT VALLEY, Ariz., July 1, 2025 /PRNewswire/ — Century Communities, Inc. (NYSE: CCS)—a top 10 national homebuilder, industry leader in online home sales, and the highest-ranked homebuilder on Newsweek's list of America's Most Trustworthy Companies 2025—is excited to announce that the Company's Century Complete brand is now selling at Point of View, a new collection of single-family homes in Prescott Valley priced from the $370s. Point of View's desirable location balances small-town charm with access to outdoor destinations, Prescott, and historic Jerome—boasting art galleries, boutique shops, and local restaurants.
Learn more, explore available homes, and buy online at www.CenturyCommunities.com/POVAZ.
'We're delivering attainable homeownership in a scenic location surrounded by abundant outdoor recreation, situated between Mingus Mountain and Prescott National Forest,' said Dave Hodgman, Executive Vice President of Field Operations. 'Homebuyers will appreciate our thoughtfully designed floor plans and streamlined online buying process. Opportunities are limited, so get in touch with our sales team today to find your best fit.'
POINT OF VIEW | PRESCOTT VALLEY, AZNow selling from the $370s
Single-family homes (all single-story floor plans)
3 to 4 bedrooms, 2 bathrooms, 2-bay garages
1,267 to 1,803 square feet
Included features such as quartz countertops, Whirlpool® stainless-steel appliances, white cabinets, and Shaw® wood-look flooring
Open-concept layouts with designer-selected finishes
Prime location near Highway 89A
Quick drive to Prescott and historic Jerome
Easy access to outdoor recreation at Prescott National Forest and Mingus Mountain
Community LocationN. Viewpoint Road and Ryder RoadPrescott Valley, AZ 86315520.213.8607
THE FREEDOM OF ONLINE HOMEBUYING
Century Complete is proud to feature its industry-first online homebuying experience on all available homes in Arizona, allowing homebuyers to easily find their best fit and purchase when they're ready—all while continuing to work with their local real estate agent of choice. Homebuyers can further streamline the homebuying process by financing online with Century Complete's affiliate lender, Inspire Home Loans®.
How it works:
Shop homes at CenturyCommunities.com
Click 'Buy Now' on any available home
Fill out a quick Buy Online form
Electronically submit an initial earnest money deposit
Electronically sign a purchase contract via DocuSign®
Learn more about the Buy Online experience at www.CenturyCommunities.com/online-homebuying.
About Century Communities
Century Communities, Inc. (NYSE: CCS) is one of the nation's largest homebuilders, an industry leader in online home sales, and one of the highest-ranked homebuilders on Newsweek's list of America's Most Trustworthy Companies 2025—consecutively awarded for a third year—and Newsweek's list of the World's Most Trustworthy Companies 2024. Through its Century Communities and Century Complete brands, Century's mission is to build attractive, high-quality homes at affordable prices to provide its valued customers with A HOME FOR EVERY DREAM®. Century is engaged in all aspects of homebuilding — including the acquisition, entitlement and development of land, along with the construction, innovative marketing and sale of quality homes designed to appeal to a wide range of homebuyers. The Company operates in 17 states and over 45 markets across the U.S., and also offers mortgage, title, insurance brokerage, and escrow services in select markets through its Inspire Home Loans, Parkway Title, IHL Home Insurance Agency, and IHL Escrow subsidiaries. To learn more about Century Communities, please visit www.centurycommunities.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
2 hours ago
- The Sun
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the 'Group')grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the 'drug, medical device and Aesthetics' field. 1、 High-end medical aesthetics: GeneQueens series At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition. GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin. In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an 'instant enjoyment' precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot. 2、金因敷 showcased a variety of new products Meanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics. 金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care. 3、The latest research data was presented at CSD2025 It is worth mentioning that 肌顏態® also showcased the research data of 'The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure' jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products. As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice. 4、Academic speeches by several experts Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®' s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing. In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time. Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends 6、The signing ceremony reflects the market potential Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: ' We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the 'Drugs, Medical device and Aesthetics' strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. ' Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as '皮優理'. The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value. The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the 'Drugs, Medical device and Aesthetics' strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.
The Star
4 hours ago
- The Star
LFG unit to offload vessel in RM32mil agreement
PETALING JAYA: Omni Victory (L) Inc, an indirect, fully owned subsidiary of Lianson Fleet Group Bhd (LFG), has entered into a memorandum of agreement (MoA) to sell the vessel Omni Victory to Huashun Shipping (Liberia) Inc for a cash sum of US$7.6mil or about RM32.02mil. Omni Victory is a Malaysian-flagged anchor handling and supply tug built in 2010 with a deadweight tonnage of 2,524 tonnes and a static bollard pull of 108 tonnes. Acquired by LFG in March 2011 for RM65.8mil, the vessel's net book value stood at RM22.57mil as of May 31. The purchaser, Huashun Shipping (Liberia) Inc, operates as a wholly owned unit of Shenzhen Huawei Offshore Shipping Transport Co Ltd. In a filing with Bursa Malaysia yesterday, LFG said it will retain no liabilities or provide any guarantees following the transaction. The sale price was negotiated on a willing-buyer, willing-seller basis, with the vessel valued at US$5.7mil by an independent valuer last December. The proposed disposal is part of LFG's ongoing fleet rejuvenation efforts to modernise and replace its fleet in line with the evolving market demands of the oil and gas industry. 'This also aligns with LFG's rebranding and long-term strategy to diversify from being a pure offshore support vessel player into other vessel asset classes, supporting our pivot towards new markets and strengthening our long-term growth and operational flexibility,' the group said in its filing. Proceeds from the sale will be directed toward general corporate purposes and to fuel LFG's growth initiatives. While the transaction will not impact LFG's issued share capital or the shareholdings of its major shareholders, it is expected to yield a net gain of approximately RM8.15mil, positively affecting LFG's earnings, net assets and gearing for this year.
Malaysian Reserve
7 hours ago
- Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HONE, FL, SAGE on Behalf of Shareholders
NEW YORK, July 1, 2025 /PRNewswire/ — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: HarborOne Bancorp (NASDAQ: HONE)'s sale to Eastern Bankshares, Inc. for either 0.765 shares of Eastern common stock or $12.00 in cash per share. If you are a HarborOne shareholder, click here to learn more about your rights and options. Foot Locker, Inc. (NYSE: FL)'s sale to DICK'S Sporting Goods, Inc. Under the terms of the proposed transaction, Foot Locker shareholders can elect to receive either (i) $24.00 in cash or (ii) 0.1168 shares of DICK'S common stock for each share of Foot Locker common stock. If you are a Foot Locker shareholder, click here to learn more about your rights and options. Sage Therapeutics, Inc. (NASDAQ: SAGE)'s sale to Supernus Pharmaceuticals, Inc. Under the terms of the proposed transaction, Sage shareholders will receive $8.50 per share in cash, plus one non-tradable contingent value right collectively worth up to $3.50 per share in cash payable upon achieving certain net sales and commercial milestones. If you are a Sage shareholder, click here to learn more about your legal rights and options. Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@ or zhalper@ Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information:Halper Sadeh LLCDaniel Sadeh, Halper, Esq.(212) 763-0060sadeh@
